Personas / Equipo Humano

Belen Arranz Martí

Buscador de publicaciones

Publicaciones

  • Rubio E, del Cacho N, Saenz-Navarrete G, Arranz B, Cambra RM, Cuadras-Palleja D, Rodante D, Fehér C, Roca M, Barneda V, Usall J and PROLACT Group.

    How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment

    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY . 36(5): 422-428. Nº de citas: 22

    [doi:10.1097/JCP.0000000000000539]

  • San L and Arranz B.

    Nalmefene: A new approach in the management of alcohol dependence disorders?

    Psiquiatría Biológica . 23(1): 29-35.

    [doi:10.1016/j.psiq.2016.02.006]

  • Arranz B, Safont G, Corripio I, Ramirez N, Maria Dueñas R, Perez V, Alvarez E and San L.

    Substance Use in Patients With First-Episode Psychosis: Is Gender Relevant?

    Journal of Dual Diagnosis . 11(3-4): 153-160. Nº de citas: 24

    [doi:10.1080/15504263.2015.1113761]

  • Srisawat U, Reynolds GP, Zhang ZJ, Zhang XR, Arranz B, San L and Dalton CF.

    Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY . 17(3): 485-490. Nº de citas: 19

    [doi:10.1017/S1461145713001375]

  • Barajas A, Usall J, Baños I, Dolz M, Villalta-Gil V, Vilaplana M, Autonell J, Sánchez Fernández B, Cervilla JA, Foix-Sanjuan A, Obiols JE, Haro JM, GENIPE group and Ochoa S.

    Three-factor model of premorbid adjustment in a sample with chronic schizophrenia and first-episode psychosis

    Schizophrenia Research . 151(1-3): 252-258. Nº de citas: 21

    [doi:10.1016/j.schres.2013.10.027]

  • Ochoa S, Huerta-Ramos ME, Barajas A, Iniesta R, Dolz M, Baños I, Sánchez Fernández B, Carlson J, Foix-Sanjuan A, Pelaez T, Coromina M, Pardo M, GENIPE group and Usall J.

    Cognitive profiles of three clusters of patients with a first-episode psychosis

    Schizophrenia Research . 150(1): 151-156. Nº de citas: 15

    [doi:10.1016/j.schres.2013.07.054]

  • Rubio E, Saenz Navarrete, G., Arranz B, Del Cacho, N., Cambra, R., Iniesta, R., Roca, M., Barneda, V. and Usall J.

    Reproductive side effects of antipsychotic-induced hyperprolactinemia; a cross-sectional study - preliminary results

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 23(2): 462-462.

    [doi:10.1016/S0924-977X(13)70731-4]

  • Salavert J, San L, Arranz B, Ramirez N and Sintes A.

    Trastornos de la personalidad del grupo B y trastorno por uso de sustancias: tipos de tratamientos y dispositivos terapéuticos

    Aula Médica Psiquiatria . 11(1): 29-51.

  • Reynolds GP, Yevtushenko OO, Gordon S, Arranz B, San L and Cooper SJ.

    The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY . 16(6): 1421-1425. Nº de citas: 24

    [doi:10.1017/S1461145712001435]

  • Ochoa S, Suarez D, Novick D, Arranz B, Roca M, Baño V and Haro JM.

    Factors predicting hostility in outpatients with schizophrenia: 36-month results from the SOHO study.

    JOURNAL OF NERVOUS AND MENTAL DISEASE . 201(6): 464-470. Nº de citas: 9

    [doi:10.1097/NMD.0b013e31829480b0]